Fierce Pharma

AUGUST 15, 2023

As the coronavirus surged and subsided, several biopharma companies experienced exaggerated revenue spikes and troughs. | Thanks to sales of their metabolism drugs, Novo Nordisk and Eli Lilly posted the biopharma industry’s largest revenue gains in the second quarter—by far. Meanwhile, only six of the industry’s top 20 firms experienced revenue decreases, with Pfizer's sales dropping a whopping 54%.

Biopharma 239

Biopharma Sales Pharma 239

PharmExec

AUGUST 15, 2023

Bridget Seay of epocrates delves into drug launches in a digital-forward market, exploring how pharmaceutical companies can navigate complex patient journeys, strike a balance between traditional and digital marketing tactics, and ethically engage with healthcare professionals and empowered patients amidst ever-changing regulations.

Ethics 98

Ethics Marketing Consulting Healthcare 98

Fierce Pharma

AUGUST 15, 2023

Speculation that Stada Arzneimittel may be looking for a buyout has largely been confirmed after the company’s CEO said as much in a recent German-language news story. | Responding to recent acquisition rumors, Stada Arzneimittel's CEO Peter Goldschmidt told the German Press Agency, “Whether and when STADA might be sold is solely the decision of our owners; Bain Capital and Cinven.

Sales 228

Sales 228

MedCity News

AUGUST 15, 2023

Santa Clara Valley Healthcare in California has begun notifying 43,000 patients about their eligibility for billing corrections and refunds. The system’s patient outreach effort is a result of a recently settled lawsuit filed against Santa Clara County. In the complaint, former patients alleged the county did not inform them about its hospitals’ charity care and discount payment policies, leading them to have to pay large bills.

Patients 95

Patients Healthcare Healthcare Leads 95

Advertisement

Distribution

Fierce Pharma

AUGUST 15, 2023

Biogen’s $7.3 billion buyout of Skyclarys-maker Reata Pharmaceuticals surprised some industry watchers last month. | Biogen’s $7.3 billion buyout of Skyclarys-maker Reata Pharmaceuticals surprised some industry watchers last month. But it turns out Biogen wasn’t the only drugmaker jockeying for the Texas-based rare disease outfit, a new securities filing shows.

Pharma 206

Pharma Pharmaceutical 206

MedCity News

AUGUST 15, 2023

The second quarter of 2023 ended with 309 active drug shortages, the highest total in nearly a decade, according to a new report from ASHP. One of the organization’s executives pointed out that drug shortages have two major impacts on health systems: they create a lot of extra work for the pharmacy department, and they force clinicians to make tough decisions about patient care that could potentially result in worse patient outcomes.

Patients 95

Patients Healthcare Healthcare 95

MedCity News

AUGUST 15, 2023

Gilead Sciences is partnering with Tentarix Biotherapeutics, a startup developing multifunctional antibody drugs that it calls “Tentacles.” Tentarix’s technology offers the potential to selectively address targets in cancer and inflammation.

Biopharma 93

Biopharma Pharma 93

Fierce Pharma

AUGUST 15, 2023

As COVID-19 vaccine makers gear up to launch updated shots in the private market, can the new vaccines keep up with the virus?

Marketing 221

Marketing 221

MedCity News

AUGUST 15, 2023

The role of the family caregiver is considered part of the cycle of life. But it can be time consuming and stressful, especially if caregivers have to balance their role with a job, raising children, and other aspects of family life. The topic will be one of many discussed at the HLTH event in Las Vegas from October 8-11.

88

88

Fierce Pharma

AUGUST 15, 2023

With its blockbuster eye drug Eylea, Regeneron is already juggling between a recent FDA rejection and new competition. Meanwhile, biosimilar players are also eying a piece of the pie. | With its blockbuster eye drug Eylea, Regeneron is already juggling between a recent FDA rejection and new competition. Meanwhile, biosimilar players are also eying a piece of the pie.

Competition 179

Competition FDA 179

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

European Pharmaceutical Review

AUGUST 15, 2023

CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. The exhibition, which will take place from 8-10 October 2024, is being hosted in Milan for the second time in three years in recognition of the massive pharmaceutical ingredients and manufacturing industry in the region.

Manufacturing 90

Manufacturing Pharma Pharmaceutical Pharmaceutical research 90

MedCity News

AUGUST 15, 2023

In-home provider MedArrive can now connect members of its payer customers, particularly Medicaid plans, to Heartbeat Health for virtual cardiovascular services, the companies announced Tuesday.

86

86

Pharmaceutical Technology

AUGUST 15, 2023

The biologic was able to halt disease progression in rheumatoid arthritis with the same effectiveness as gold-standard treatment Remicade.

98

98

MedCity News

AUGUST 15, 2023

Generative AI further enhances the value of prompt engineering by synthesizing important insights from various interactions, including text, images, compliant transcripts, and call notes. By automating this process, generative AI quickly transforms on-the-ground insights into robust analytics.

Engineering 86

Engineering Pharma Manufacturing Biopharma 86

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Pharmaceutical Commerce

AUGUST 15, 2023

Analysis requested by PhRMA indicates that these facilities charge anywhere from two to seven times what they originally paid.

Medical 97

Medical 97

MedCity News

AUGUST 15, 2023

Immune checkpoint inhibitors are effective cancer treatments, but are expensive. Understanding the least-costly settings for administering treatments, leveraging genomic testing and following evidence-based guidelines can help health plans optimize cancer care, according to Evernorth Research Institute.

85

85

PharmaVoice

AUGUST 15, 2023

Drugs like the buzzy Ozempic are high on consumers’ radar — but lofty barriers to access remain.

98

98

MedCity News

AUGUST 15, 2023

Oncology is already a big piece of Pfizer’s drug lineup. The portfolio is expanding to multiple myeloma with FDA approval of Elrexfio, a bispecific antibody that targets the cancer protein BCMA.

FDA 81

FDA Biopharma Pharma 81

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

PharmaTimes

AUGUST 15, 2023

The study is specifically analysing the company’s new enteric coated tablet formation of the drug - News - PharmaTimes

77

77

Clarify Health

AUGUST 15, 2023

More than just a buzzword, healthcare price transparency has become a pivotal tool for helping providers negotiate better contracts with payers. Providers can use price transparency data to enhance contracting efficiency, demonstrate value to improve their position, and, ultimately, help propel greater affordability for patients. Understanding healthcare price transparency Historically, healthcare contracting, billing practices, and prices have been shrouded in mystery.

Insurance 52

Insurance Competition Healthcare Healthcare 52

PharmaTimes

AUGUST 15, 2023

The study concerns the use of Nefecon among adult patients with primary IgA nephropathy - News - PharmaTimes

Patients 76

Patients 76

PharmaVoice

AUGUST 15, 2023

The oncology portfolio general manager for breast and women’s cancers, discusses the company’s recent “landmark” trial and how her family’s history connects her to patients.

Management 52

Management Patients 52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

PharmaTech

AUGUST 15, 2023

Introducing Lonza Capsules & Health Ingredients' groundbreaking enteric manufacturing technology - the Capsugel® Enprotect® capsule. This unique bi-layer capsule with the Coni-Snap® secure closure design ensures leak-free containment and maximum delivery of APIs. By utilizing HPMC and HPMC-AS polymers, it protects acid-sensitive APIs and enables rapid dissolution release at pH 6.8 without the need for additional excipients.

Manufacturing 52

Manufacturing Healthcare Healthcare Marketing 52

Evolve Your Success

AUGUST 15, 2023

From spine medical sales to visionary leadership: Join us in celebrating a remarkable milestone as we present the 150th episode of our podcast, featuring the accomplished Shannon Mays with host Samuel Adeyinka. Shannon reveals how three years of growth can transform careers and industries alike. He shares his inspiring journey from an entry-level position in the world of spine medical sales to becoming a visionary leader and an invaluable contributor to the industry.

Medical sales 52

Medical sales Sales Medical Specialization 52

Spotio

AUGUST 15, 2023

You’re a field sales rep, so you spend a lot of time on the road, traveling from one prospect to the next. The question is, do you spend this time wisely? The best sales podcasts will help make sure you do. Podcasts have been around for nearly two decades, but they’ve only become popular in the last few years. How popular? There are now 100 million podcast listeners in the US alone.

Sales 52

Sales B2B Sales Sales pipeline Prospecting 52

PharmaTech

AUGUST 15, 2023

The completion of three acquisitions of Versanis Bio, Sigilon Therapeutics, and DICE Therapeutics boosts Eli Lilly and Company’s product pipeline in obesity, diabetes, and immunology.

52

52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PM360

AUGUST 15, 2023

Adheris Health, a MedAdvisor company, announced today that they have rebranded as MedAdvisor Solutions as part of a global initiative to consolidate the MedAdvisor business units and B2B brands into one global B2B brand and enterprise structure. This rebrand unifies MedAdvisor Solutions as a global leader of innovative, pharmacy-driven patient engagement solutions.

Retail 52

Retail Networking Patients Management 52

Pharmaceutical Technology

AUGUST 15, 2023

According to GlobalData’s recent von Willebrand Disease (vWD): Opportunity Analysis and Forecast report, the vWD market is expected to see significant growth during the 2022–32 forecast period

Marketing 52

Marketing 52

Legacy MEDSearch

AUGUST 15, 2023

Viseon Inc. announced the US commercial rollout and initial clinical use of the First-of-its-Kind 4K Advanced Visualization System for Minimally Invasive Spine Surgery. The Viseon MaxView 4K System is an enabling, towerless, state-of-the-art, advanced visualization system involving no capital equipment expense and occupying no operating room footprint, most accommodating in an ASC setting.

Safety 52

Safety Recruitment Medical Patients 52

Rep-Lite

AUGUST 15, 2023

In the ever-evolving landscape of medical devices, achieving sales success goes beyond traditional selling techniques. Clinical specialists play a pivotal role in bridging the gap between product knowledge and real-world applications. These highly skilled professionals bring valuable expertise and insights, enabling sales teams to make informed decisions and drive sales in the competitive healthcare market.

Medical 52

Medical Sales Product Knowledge Sales Strategy 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management